/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Interleukin 6 in asymptomatic patients with nonsevere aortic valve stenosis: a post-hoc study of the SEAS trial
Event: ESC Congress 2024
Topic: Biomarkers
Session: Biomarkers to assess cardiovascular risk
Development and validation of the ASGARD-S risk score for optimal timing of echocardiograms in asymptomatic patients with non-severe aortic valve stenosis: the SEAS and SALTIRE II trials
Event: ESC Congress 2024
Topic: Scores
Session: Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis
Validation of the developed ASGARD risk score for safe monitoring of asymptomatic patients with non-severe aortic valve stenosis
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Improving risk stratification in aortic stenosis: from the valve to the ventricle
ASGARD risk scores for long-term, individualized cardiovascular surveillance of low-risk patients with asymptomatic non-severe aortic valve stenosis: development and internal validation
Event: ESC Congress 2023
Topic: Scores
Session: Cardiovascular risk assessment: scores (2)
High-sensitive Troponin T is not associated with the progression of asymptomatic mild to moderate aortic stenosis: a post hoc substudy of the SEAS trial
Event: ESC Congress 2022
Topic: Biomarkers
Session: Cardiovascular risk assessment - Biomarkers 2
High-sensitive Troponin T in asymptomatic aortic stenosis
Event: ESC Congress 2020
Topic: Diagnostic Methods
Session: Valvular Heart Disease ePosters
Osborn waves do not increase risk of arrhythmia in contemporary post cardiac arrest care
Event: Acute Cardiovascular Care 2018
Topic: Management of Out of Hospital Cardiac Arrest
Session: Moderated Poster Session 6 - Arrhythmias
